St. Laurent, Joseph P.,Jones, Gerald S.,Bresse, David M.
申请号：
AU2013274579
公开号：
AU2013274579B2
申请日:
2013.06.06
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
